Literature DB >> 34030805

Mechanical ventilation in neurocritical care setting: A clinical approach.

Denise Battaglini1, Dorota Siwicka Gieroba2, Iole Brunetti3, Nicolò Patroniti4, Giulia Bonatti5, Patricia Rieken Macedo Rocco6, Paolo Pelosi7, Chiara Robba8.   

Abstract

Neuropatients often require invasive mechanical ventilation (MV). Ideal ventilator settings and respiratory targets in neuro patients are unclear. Current knowledge suggests maintaining protective tidal volumes of 6-8 ml/kg of predicted body weight in neuropatients. This approach may reduce the rate of pulmonary complications, although it cannot be easily applied in a neuro setting due to the need for special care to minimize the risk of secondary brain damage. Additionally, the weaning process from MV is particularly challenging in these patients who cannot control the brain respiratory patterns and protect airways from aspiration. Indeed, extubation failure in neuropatients is very high, while tracheostomy is needed in one-third of the patients. The aim of this manuscript is to review and describe the current management of invasive MV, weaning, and tracheostomy for the main four subpopulations of neuro patients: traumatic brain injury, acute ischemic stroke, subarachnoid hemorrhage, and intracerebral hemorrhage.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  acute brain injury; mechanical ventilation; neurocritical care; tracheostomy; weaning

Mesh:

Year:  2020        PMID: 34030805     DOI: 10.1016/j.bpa.2020.09.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Anaesthesiol        ISSN: 1521-6896


  2 in total

Review 1.  Mechanical Ventilation in Patients with Traumatic Brain Injury: Is it so Different?

Authors:  Shaurya Taran; Sung-Min Cho; Robert D Stevens
Journal:  Neurocrit Care       Date:  2022-09-07       Impact factor: 3.532

Review 2.  Brain-lung interactions and mechanical ventilation in patients with isolated brain injury.

Authors:  Mairi Ziaka; Aristomenis Exadaktylos
Journal:  Crit Care       Date:  2021-10-13       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.